Nalaganje...

Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges

Tremendous efforts have been made over the past few decades to discover novel cancer biomarkers for use in clinical practice. However, a striking discrepancy exists between the effort directed toward biomarker discovery and the number of markers that make it into clinical practice. One of the confou...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Füzéry, Anna K, Levin, Joshua, Chan, Maria M, Chan, Daniel W
Format: Artigo
Jezik:Inglês
Izdano: Springer 2013
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3850675/
https://ncbi.nlm.nih.gov/pubmed/24088261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1559-0275-10-13
Oznake: Označite
Brez oznak, prvi označite!